You are now leaving the pages of www.gilead.com intended for U.S. audiences. The information in this section is intended for visitors outside the United States.
Pharmacia & Upjohn and Gilead Sciences Receive European Recommendation for VISTIDE®
Gilead Sciences Commences Human Clinical Testing of Systemic PMPA for HIV
Hoffmann-La Roche, Gilead Sciences Announce Collaboration to Co-promote Potential Hepatitis C Treatment in the U.S.
Gilead Sciences, Hoffman-La Roche Announce Worldwide Influenza Collaboration
Gilead Sciences Announces Discovery of Orally Active Influenza Inhibitors
Gilead Sciences Announces Statistically Significant Antiviral Activity Against Hepatitis B Virus
Pharmacia & Upjohn and Gilead Sciences Announce Marketing Collaboration Outside of the U.S. for New AIDS-related Drug, VISTIDE®
FDA Grants Marketing Clearance of Gilead's VISTIDE® for the Treatment of CMV Retinitis in Patients with AIDS
2012 Interactive Annual Report